Tyrosine Kinase Receptors Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Tyrosine Kinase Receptors stocks.

Tyrosine Kinase Receptors Stocks Recent News

Date Stock Title
May 2 BBIO BridgeBio Pharma GAAP EPS of -$0.20 beats by $0.31, revenue of $211.12M beats by $127.34M
May 2 BBIO BridgeBio Pharma Reports First Quarter 2024 Financial Results and Business Update
May 2 BBIO BridgeBio launches BridgeBio Oncology Therapeutics (BBOT) with $200M of private external capital to accelerate the development of its novel precision oncology pipeline
May 2 BBIO BridgeBio spinout launches with $200M for KRAS cancer drugs
May 1 PBYI Puma Biotechnology Q1 2024 Earnings Preview
May 1 BBIO Pfizer’s strong Vyndaqel sales draw attention to rare disease drug’s patent life
Apr 30 MACK Merrimack Pharmaceuticals announces notification of plan to delist common stock on Nasdaq
Apr 30 MACK Merrimack Pharmaceuticals Announces Notification of Plan to Voluntary Delist Common Stock on NASDAQ Subject to Receipt of Stockholder Approval of Plan of Dissolution
Apr 30 DCPH ONO to acquire Deciphera Pharmaceuticals in $2.4B deal
Apr 30 DCPH Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion
Apr 29 DCPH Why Is Cancer Focused Deciphera Pharmaceuticals Stock Skyrocketing On Monday?
Apr 29 DCPH Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Apr 29 DCPH Ono Pharmaceutical acquires cancer-focused biopharma Deciphera for $2.4bn
Apr 29 DCPH Deciphera Agrees to $2.4 Billion Buyout Offer From Japan's ONO Pharmaceutical
Apr 29 DCPH Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
Apr 29 DCPH Deciphera Pharmaceuticals Is Being Acquired and the Stock Soars 72%
Apr 29 DCPH Update: Deciphera Pharmaceuticals to Be Acquired by ONO Pharmaceutical in $2.4 Billion Deal
Apr 29 PBYI Is Puma Biotechnology, Inc. (NASDAQ:PBYI) A High Quality Stock To Own?
Apr 29 DCPH Deciphera stock soars after Ono Pharmaceutical’s $2.4B buyout deal
Apr 29 DCPH Deciphera to sell for $2.4B, adding to upswing in biopharma M&A
Tyrosine Kinase Receptors

Tyrosine kinase receptors are a type of cell surface receptor that binds to specific molecules and activates a signal transduction pathway inside the cell. They are involved in a wide range of cellular processes, including cell growth, differentiation, and migration. They are also involved in the regulation of the immune system and in the development of cancer.

Browse All Tags